Together, these two seemingly contradictory observations imply that the antitumor effect of PPARα may be two-pronged; complete absence of PPARα expression allows tumor clearance by the host's immune system while agonist-induced stimulation of PPARα prohibits the exaggerated inflammatory responses of the host that can aggravate tumor development [29, 30]. The gene discussed is PPARA; the disease is neoplasm.